Feb 21, 2019 - Studies have shown that Masimo's (MASI) SET pulse oximetry can improve CCHD screening, helping to save newborns.
Feb 20, 2019 - Strong domestic sales along with the launch of the t:slim X2 Insulin Pump in select international markets are likely to drive Tandem Diabetes' (TNDM) Q4 earnings.
Feb 18, 2019 - Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4.
Feb 12, 2019 - DaVita (DVA) expects headwinds in DaVita Rx, while overseas prospects of the dialysis business look bright.
Feb 11, 2019 - Ecolab's (ECL) preliminary Q4 earnings are likely to fall short of estimates.
Feb 05, 2019 - Medical Instruments companies are likely to gain from strong performance in emerging economies and modernization of 510 (k)-clearance pathway by the FDA in Q4.
Feb 04, 2019 - Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q2; medical-gloves sub-segment likely to be soft.
Jan 28, 2019 - Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Jan 10, 2019 - Wall Street rallied for the fourth successive day owing to positive developments on the trade front and Fed Chair???s indication of maintaining caution on further interest rate hikes.
Jan 10, 2019 - Masimo (MASI) issues guidance for 2019. It anticipates witnessing strong contribution from its core product revenue segment.